The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Drug Design by Pharmacophore and Virtual Screening Approach
Open accessAbstract
Computer-aided drug discovery techniques reduce the time and the costs needed to develop novel drugs. Their relevance becomes more and more evident with the needs due to health emergencies as well as to the diffusion of personalized medicine. Pharmacophore approaches represent one of the most interesting tools developed, by defining the molecular functional features needed for the binding of a molecule to a given receptor, and then directing the virtual screening of large collections of compounds for the selection of optimal candidates. Computational tools to create the pharmacophore model and to perform virtual screening are available and generated successful studies. This article describes the procedure of pharmacophore modelling followed by virtual screening, the most used software, possible limitations of the approach, and some applications reported in the literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Genheden, S., & Ryde, U. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1032936 · Cited by 5,534
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
PubChem in 2021: new data content and improved web interfaces
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa971 · Cited by 3,953
Cramer, R. D., Patterson, D. E., & Bunce, J. D. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00226a005 · Cited by 3,931
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
Wolber, G., & Langer, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049885e · Cited by 1,954
Klebe, G., Abraham, U., & Mietzner, T. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00050a010 · Cited by 1,816
Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G. V., Christie, C. H., Dalenberg, K., Di Costanzo, L., Duarte, J. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1038 · Cited by 1,581 · cited 4×
“An interface to the Protein Data Bank is also provided (by Py-PDB) [69].”
BackgroundInfluentialBenchmarking sets for molecular docking.
Huang, N., Shoichet, B. K., & Irwin, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0608356 · Cited by 1,318
Using AutoDock for Ligand‐Receptor Docking
Morris, G. M., Huey, R., & Olson, A. J. (2008) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0814s24 · Cited by 1,293
Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9087-6 · Cited by 1,198
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Lionta, E., Spyrou, G., Vassilatis, D., & Cournia, Z. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140929124445 · Cited by 1,165
Protein–ligand docking: Current status and future challenges
Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21082 · Cited by 1,004
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Yang, S.-Y. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.013 · Cited by 901
The computer program LUDI: A new method for the de novo design of enzyme inhibitors
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 835
DOCK 6: Impact of new features and current docking performance
Allen, W. J., Balius, T. E., Mukherjee, S., Brozell, S. R., Moustakas, D. T., Lang, P. T., Case, D. A., Kuntz, I. D., & Rizzo, R. C. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23905 · Cited by 833
Wang, Y., Bryant, S. H., Cheng, T., Wang, J., Gindulyte, A., Shoemaker, B. A., Thiessen, P. A., He, S., & Zhang, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1118 · Cited by 671
Triballeau, N., Acher, F., Brabet, I., Pin, J.-P., & Bertrand, H.-O. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049092j · Cited by 631
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Maia, E. H. B., Assis, L. C., de Oliveira, T. A., da Silva, A. M., & Taranto, A. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00343 · Cited by 588
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998) · Pure and Applied Chemistry · doi:10.1351/pac199870051129 · Cited by 529
ZINCPharmer: pharmacophore search of the ZINC database
Koes, D. R., & Camacho, C. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks378 · Cited by 436
Pharmit: interactive exploration of chemical space
Sunseri, J., & Koes, D. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw287 · Cited by 420
Normal mode analysis of protein dynamics
Case, D. A. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90321-2 · Cited by 384
Homology modeling in drug discovery: Overview, current applications, and future perspectives
Muhammed, M. T., & Aki‐Yalcin, E. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13388 · Cited by 358
Virtual Screening in Drug Discovery - A Computational Perspective
Reddy, A. S., Pati, S. P., Kumar, P. P., Pradeep, H. N., & Sastry, G. N. (2007) · Current Protein & Peptide Science · doi:10.2174/138920307781369427 · Cited by 350
Recent advances in computer-aided drug design
Song, C. M., Lim, S. J., & Tong, J. C. (2009) · Briefings in Bioinformatics · doi:10.1093/bib/bbp023 · Cited by 344
Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis
Salam, N. K., Nuti, R., & Sherman, W. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900212v · Cited by 323
Identification of Common Functional Configurations Among Molecules
Barnum, D., Greene, J., Smellie, A., & Sprague, P. (1996) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci950273r · Cited by 319
Efficient overlay of small organic molecules using 3D pharmacophores
Wolber, G., Dornhofer, A. A., & Langer, T. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9078-7 · Cited by 312
The US Federal Tox21 Program: A strategic and operational plan for continued leadership
Thomas, R. (2018) · ALTEX · doi:10.14573/altex.1803011 · Cited by 229
Kaserer, T., Beck, K., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 207
Lu, S.-H., Wu, J. W., Liu, H.-L., Zhao, J.-H., Liu, K.-T., Chuang, C.-K., Lin, H.-Y., Tsai, W.-B., & Ho, Y. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-8 · Cited by 204
An Updated Review of Computer‐Aided Drug Design and Its Application to COVID‐19
Gurung, A. B., Ali, M. A., Lee, J., Farah, M. A., & Al-Anazi, K. M. (2021) · BioMed Research International · doi:10.1155/2021/8853056 · Cited by 201
Carpenter, K. A., & Huang, X. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180607124038 · Cited by 197
Pal, S., Kumar, V., Kundu, B., Bhattacharya, D., Preethy, N., Reddy, M. P., & Talukdar, A. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.02.006 · Cited by 197
Rahman, N., Basharat, Z., Yousuf, M., Castaldo, G., Rastrelli, L., & Khan, H. (2020) · Molecules · doi:10.3390/molecules25102271 · Cited by 183
Multi-dimensional QSAR in drug discovery
Lill, M. A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.08.004 · Cited by 159
Designing ligands to bind proteins
Whitesides, G. M., & Krishnamurthy, V. M. (2005) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583506004240 · Cited by 139
Strategies for 3D pharmacophore-based virtual screening
Seidel, T., Ibis, G., Bendix, F., & Wolber, G. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.11.004 · Cited by 137
Vuorinen, A., & Schuster, D. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.013 · Cited by 133
Pocket v.2: Further Developments on Receptor-Based Pharmacophore Modeling
Chen, J., & Lai, L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci600246s · Cited by 129
How far can virtual screening take us in drug discovery?
Kar, S., & Roy, K. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.761204 · Cited by 128
Recent theoretical and computational advances for modeling protein–ligand binding affinities
Gallicchio, E., & Levy, R. M. (2011) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-386485-7.00002-8 · Cited by 123
Sanders, M. P. A., McGuire, R., Roumen, L., de Esch, I. J. P., de Vlieg, J., Klomp, J. P. G., & de Graaf, C. (2011) · MedChemComm · doi:10.1039/c1md00210d · Cited by 114
Schuster, D., Maurer, E. M., Laggner, C., Nashev, L. G., Wilckens, T., Langer, T., & Odermatt, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600794 · Cited by 110
Applications of the Pharmacophore Concept in Natural Product inspired Drug Design
Seidel, T., Wieder, O., Garon, A., & Langer, T. (2020) · Molecular Informatics · doi:10.1002/minf.202000059 · Cited by 105
The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design
Seidel, T., Schuetz, D. A., Garon, A., & Langer, T. (2019) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-030-14632-0_4 · Cited by 96
Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations
Wieder, M., Garon, A., Perricone, U., Boresch, S., Seidel, T., Almerico, A. M., & Langer, T. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00674 · Cited by 77
Structure-based molecular modeling in SAR analysis and lead optimization
Temml, V., & Kutil, Z. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.018 · Cited by 77
Pharmacophore Modelling: A Forty Year Old Approach and its Modern Synergies
Caporuscio, F., & Tafi, A. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795933669 · Cited by 75
A General Picture of Cucurbit[8]uril Host–Guest Binding
Sun, Z., He, Q., Gong, Z., Kalhor, P., Huai, Z., & Liu, Z. (2021) · Molecules · doi:10.1021/acs.jcim.1c01208 · Cited by 74
Song, T., Zhang, X., Ding, M., Rodríguez‐Patón, A., Wang, S., & Wang, G. (2022) · Methods · doi:10.1016/j.ymeth.2022.02.007 · Cited by 71
Interaction entropy for computational alanine scanning in protein–protein binding
Qiu, L., Yan, Y., Sun, Z., Song, J., & Zhang, J. Z. H. (2017) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1342 · Cited by 65
Ragno, R. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00231-x · Cited by 61
Danishuddin, M., & Khan, A. U. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.019 · Cited by 60
Drug Syntheses Beyond the Rule of 5
Tyagi, M., Begnini, F., Poongavanam, V., Doak, B. C., & Kihlberg, J. O. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201902716 · Cited by 59
Prathipati, P., Dixit, A., & Saxena, A. K. (2007) · Current Computer - Aided Drug Design · doi:10.2174/157340907780809516 · Cited by 57
Methods for Predicting Protein–Ligand Binding Sites
Xie, Z., & Hwang, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1465-4_17 · Cited by 56
Voet, A. R. D., Banwell, E. F., Sahu, K. K., Heddle, J. G., & Zhang, K. Y. J. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313090003 · Cited by 41
Choudhury, C., & Sastry, G. N. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-05282-9_2 · Cited by 39
Dotolo, S., Cervellera, C., Russo, M., Russo, G. L., & Facchiano, A. M. (2021) · Molecules · doi:10.3390/molecules26020492 · Cited by 34
Self-citationDamm‐Ganamet, K. L., Arora, N. R., Bécart, S., Edwards, J. P., Lebsack, A. D., McAllister, H., Nelen, M. I., Rao, N. L., Westover, L., Wiener, J. J. M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00941 · Cited by 33
Sebastiano, M. R., Ermondi, G., Hadano, S., & Caron, G. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.12.018 · Cited by 28
Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations
Полищук, П. Г., Kutlushina, A., Bashirova, D., Mokshyna, O., & Madzhidov, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235834 · Cited by 27
Drug discovery FAQs: workflows for answering multidomain drug discovery questions
Chichester, C. H., Digles, D., Siebes, R., Loizou, A., Groth, P., & Harland, L. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.006 · Cited by 22
Progress in the Chemistry of Organic Natural Products 110
(2019) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-030-14632-0 · Cited by 21
Cheminformatics Explorations of Natural Products
Prieto-Martínez, F. D., Norinder, U., & Medina‐Franco, J. L. (2019) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-030-14632-0_1 · Cited by 20
Chandrasekaran, B., Agrawal, N., & Kaushik, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20276-8 · Cited by 14
Cervellera, C., Russo, M., Dotolo, S., Facchiano, A. M., & Russo, G. L. (2021) · Molecules · doi:10.3390/molecules26195810 · Cited by 5
Self-citationLombino, J., Gulotta, M. R., Simone, G. D., Mekni, N., Rosa, M. D., Carbone, D., Parrino, B., Cascioferro, S., Diana, P., Padova, A., et al. (2020) · Molecular Informatics · doi:10.1002/minf.202000148 · Cited by 1
Research works printed but not linked: 5
- Singh, D.B., and Pathak, R.K. (2021). Pharmacophore modeling and its application. Bioinformatics: Methods and Applications, Academic Press.
- Mitra, 2010, Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers, J. Mol. Model., 16, 1585, 10.1007/s00894-010-0661-4 · doi:10.1007/s00894-010-0661-4
- Boz, E., and Stein, M. (2021). Accurate Receptor-Ligand Binding Free Energies from Fast QM Conformational Chemical Space Sampling. Int. J. Mol. Sci., 22. · doi:10.3390/ijms22063078
- Sutter, 2011, New features that improve the pharmacophore tools from Accelrys, Curr. Comput. Aided Drug Des., 7, 173, 10.2174/157340911796504305 · doi:10.2174/157340911796504305
- Dror, 2008, PharmaGist: A webserver for ligand-based pharmacophore detection, Nucleic Acids Res., 36, W223, 10.1093/nar/gkn187 · doi:10.1093/nar/gkn187
Cited by
Chunarkar-Patil, P., Kaleem, M., Mishra, R., Ray, S., Ahmad, A., Verma, D., Bhayye, S., Dubey, R., Singh, H., & Kumar, S. (2024) · Biomedicines · doi:10.3390/biomedicines12010201 · Cited by 390
Barraza, G. A., Castro-Guijarro, A. C., de la Fuente Hoffmann, V., Bolívar Ávila, S. J., Flamini, M. I., & Sanchez, A. M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108988 · Cited by 9
Metadata
- Authors
- Giordano, D., Biancaniello, C., Argenio, M. A., & Facchiano, A.
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2022-05-23
- Volume
- 15
- Issue
- 5
- Pages
- 646
- ISSN
- 1424-8247 (ISSN-L)
- OpenAlex
- W4281476460
- Cited by
- 384
- References
- 75
- FWCI
- 36.49
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- CIR01_00017-“CNRBiOmics–Centro Nazionale di Ricerca in Bioinformatica per le Scienze “Omiche”–Rafforzamento del capitale umano (MUR, CUP B56J20000960001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.